Success Metrics

Clinical Success Rate
86.4%

Based on 19 completed trials

Completion Rate
86%(19/22)
Active Trials
6(18%)
Results Posted
5%(1 trials)
Terminated
3(9%)

Phase Distribution

Ph phase_4
1
3%
Ph not_applicable
14
41%
Ph phase_1
4
12%

Phase Distribution

4

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution19 total trials
Phase 1Safety & dosage
4(21.1%)
Phase 4Post-market surveillance
1(5.3%)
N/ANon-phased studies
14(73.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

82.6%

19 of 23 finished

Non-Completion Rate

17.4%

4 ended early

Currently Active

6

trials recruiting

Total Trials

34

all time

Status Distribution
Active(7)
Completed(19)
Terminated(4)
Other(4)

Detailed Status

Completed19
unknown4
Recruiting4
Terminated3
Active, not recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
34
Active
6
Success Rate
86.4%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (21.1%)
Phase 41 (5.3%)
N/A14 (73.7%)

Trials by Status

withdrawn13%
unknown412%
active_not_recruiting26%
not_yet_recruiting13%
recruiting412%
terminated39%
completed1956%

Recent Activity

Clinical Trials (34)

Showing 20 of 34 trialsScroll for more
NCT07437183Not Applicable

A Multicenter Clinical Study on the Optimization of Timing and Efficacy Evaluation of Bronchoscopic Intervention in Pediatric Severe Pneumonia

Not Yet Recruiting
NCT03784781

Type 2 Innate Lymphoid Cells in Severe Pediatric Asthma

Withdrawn
NCT07130110Not Applicable

BAL Contribution to Lung Cryo-TBB in ILD

Completed
NCT05846620

Pulmonary Immune Cell-microbiome Interactions in the Healthy Lung

Recruiting
NCT05795257

Pulmonary Immune Cell-microbiome Interactions in ARDS

Recruiting
NCT06726356Not Applicable

Value of Bronchoalveolar Lavage with Acetylcysteine in the Treatment of Bronchiectasis.

Recruiting
NCT04904692

Virological and Immunological Monitoring in Patients (suspected Of/confirmed With) COVID-19

Active Not Recruiting
NCT03498963Not Applicable

Pathogens Responsible for Respiratory Infections Associated With Drowning in Seawater

Completed
NCT05602259Not Applicable

PROspective Trial on EOsinophilia in Non-Small Cell Lung Cancer (NSCLC).

Recruiting
NCT01475500

Nashville Early Diagnosis Lung Cancer Project

Active Not Recruiting
NCT06022198Not Applicable

Bronchoalveolar Lavage in Recovered From COVID-19 Pneumonia

Completed
NCT04318691

Netosis in Determination of Respiratory Infection Severity

Completed
NCT04766983

Incidence of VAP in Patients With Severe COVID-19

Completed
NCT05403489

Comparison of the Results of Bronchoalveolar Lavage Culture and Endotracheal Aspirate Culture in Intubated Critically Ill COVID-19 Patients

Completed
NCT03691584Phase 1

Phase 1, Safety and Bronchopulmonary PK Study in Healthy Volunteers

Completed
NCT04318392

Breath Analysis in Patients With Suspected Sarcoidosis: The VOCs-IS Study

Completed
NCT04935450

Pulmonary Inflammation in COVID-19 ARDS

Unknown
NCT04911244Not Applicable

Diagnostic Modalities for VAP Detection

Completed
NCT04827667

Impact of PD1-lymphocytes in Bronchoalveolar Lavage of Patients With Lung Cancer

Unknown
NCT00094406Phase 1

Carbon Monoxide to Prevent Lung Inflammation

Completed

Drug Details

Intervention Type
PROCEDURE
Total Trials
34